Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

St Jude's LightLab files new lawsuit against Volcano's Axsun

This article was originally published in Clinica

Executive Summary

St Jude Medical subsidiary LightLab is persisting in its legal battle with rival Axsun Technologies, a subsidiary of Volcano, by filing a new lawsuit which claims that Axsun used LightLab's trade secret information to develop its optical coherence tomography technology. This is the second lawsuit that LightLab has filed in relation to this matter: earlier this year, the Superior Court of Massachusetts rejected LightLab's similar claims after two years of litigation (www.clinica.co.uk, 24 February 2011). Volcano incurred $4.9m in legal expenses, as well as its own litigation costs of $2.8m. The latest lawsuit was filed in a Delaware court. San Diego, California-based Volcano denies the "unfounded" allegations. "Volcano firmly believes that this latest lawsuit has no merit, and looks forward to the opportunity of proving so in court".

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT097344

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel